Document is current
Any future updates will be listed below
-
Authors
Kemper, Kristel
Gielen, Ellis
Houtkamp, Mischa
Boross, Peter
Burm, Saskia
Poot, Stefanie De
Engelberts, Patrick
Goeij, Bart de
Satijn, David
Sasser, Kate
Breij, Esther
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04424641 at ClinicalTrials.govDocuments that mention this clinical trial
704 Preclinical mechanism of action and pharmacodynamic biomarker studies of DuoBody®-CD3x5T4 in vitro and in vivo in solid cancer models
https://doi.org/10.1136/jitc-2020-sitc2020.0704
889 DuoBody®-CD3x5T4 induces efficient T-cell activation and killing of patient-derived head and neck cancer cells in vitro and ex vivo
https://doi.org/10.1136/jitc-2021-sitc2021.889
- License Information
